Breast Cancer Highlights From ASCO 2026: ADCs, Biomarkers, and Earlier Treatment Strategies Take Center Stage

Amol Akhade: What The Devil Wears Prada 2 Taught Me About Oncology?

Alexandre Chan: Real-World Safety of Antibody–Drug Conjugates

Christopher Jackson: If Innovation Is the Heart of Oncology, Then Access Must Be Its Conscience

ESTRO-EORTC Expert Guideline on Target Delineation and Radiotherapy for Stage I–III Small Cell Lung Cancer

IMMUNIB Study Uptades: Nivolumab Plus Lenvatinib in Unresectable HCC

Hesham ElGhazaly: Meeting Global Oncology Leaders at ASCO 2026

Khizra Ahmad: Covering ASCO26 from Front-Row Seat as OncoDaily Ambassador

Calculators

Body Mass Index (BMI)

Cockcroft-Gault Creatinine Clearance Calculator

BSA Calculator – Body Surface Area

Carboplatin Dose Calculator (Calvert Formula)

Child-Pugh Score Calculator

ECOG Score Calculator

IBW / Adjusted Body Weight (Devine Formula)

Bone Scan Index (BSI) Tracker

Khorana Score (Cancer-Associated VTE Risk)

MASCC Risk Index Calculator (Febrile Neutropenia)

IMDC Risk Score Calculator (Metastatic RCC)

Oncotype DX Recurrence Score (RS) Categorizer

Cisplatin Cumulative Dose Toxicity Tracker

Khorana Score (Cancer-Associated VTE Risk)

Estimate VTE risk in ambulatory cancer patients using the validated Khorana score.

Khorana Score Points:

  • Very high-risk site (Stomach, Pancreas): +2
  • High-risk site (Lung, Lymphoma, Gynecologic, Bladder, Testicular): +1
  • Platelets ≥350 ×10⁹/L: +1
  • Hemoglobin <10 g/dL or ESA use: +1
  • WBC >11 ×10⁹/L: +1
  • BMI ≥35 kg/m²: +1

Risk Categories:

  • Low risk: 0 points
  • Intermediate risk: 1-2 points
  • High risk: ≥3 points